Afasci Afasci

Codexis, Inc., based in Redwood City, CA, is a leading enzyme engineering company known for its proprietary CodeEvolver technology platform. Specializing in the discovery, development, and enhancement of high-performance enzymes and other proteins, Codexis tackles challenges in small molecule pharmaceutical manufacturing and nucleic acid synthesis. The company is at the forefront of developing the ECO Synthesis platform to facilitate the large-scale production of RNAi therapeutics through an enzymatic approach, offering solutions for improved yields, energy efficiency, waste reduction, and enhanced sensitivity in genomic and diagnostic applications. With a focus on driving innovation and sustainability in enzyme technology, Codexis' unique enzymes are designed to optimize manufacturing processes, delivering tangible benefits such as increased efficiency and reduced environmental impact. Leveraging its expertise in enzyme-catalyzed reactions, Codexis is committed to advancing the field of biocatalysis and shaping the future of precision medicine and biopharmaceutical production.Generated from the website

Personalis is a biotechnology company based in Menlo Park, CA. They specialize in providing advanced genomic sequencing and analysis services to support precision medicine and drug development. With a focus on delivering personalized insights into genetic variations, Personalis helps researchers and healthcare professionals make informed decisions for improved patient outcomes. Their cutting-edge technology and expertise in genomics contribute to advancements in the field of personalized medicine. Generated from their business information

Omniox Inc is a San Carlos, CA-based biotherapeutics company focused on developing innovative HNOX platform technology into first-in-class and best-in-class OMX oxygen delivery vehicles. Their engineered biologics aim to safely deliver oxygen to hypoxic tissues, addressing significant unmet medical needs and improving patient outcomes. By specifically targeting and oxygenating pathologically hypoxic tissues, Omniox's products have the potential to restore normal tissue function, ultimately leading to improved outcomes and potential cures for various diseases driven by low oxygen levels. Generated from the website